阿托伐他汀钙片联合冠心宁片治疗颈动脉粥样硬化斑块临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R543.5

基金项目:

浙江省医学会临床科研资金项目(2019ZYC-A72)


Clinical Study on Atorvastatin Calcium Combined with Guanxinning Tablets for Carotid Atherosclerotic Plaque
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察阿托伐他汀钙片联合冠心宁片治疗颈动脉粥样硬化斑块的临床疗效及其安全性。方法:选择98 例颈动脉粥样硬化斑块患者进行前瞻性研究,随机分为研究组和对照组各49 例。对照组服用阿托伐他汀钙片治疗,研究组在对照组的基础上服用冠心宁片治疗,2 组均连续治疗3 个月。观察比较2 组治疗前后颈动脉内中膜厚度(IMT)、最大斑块面积,以及甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C) 水平变化,并统计2 组临床疗效及不良反应情况。结果:研究组总有效率为97.96%,对照组为89.80%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组IMT、最大斑块面积比较,差异无统计学意义(P>0.05);治疗后,2 组IMT、最大斑块面积均较治疗前减少(P<0.05),且研究组IMT、最大斑块面积均小于对照组(P<0.05)。治疗前,2 组TG、TC、HDL-C、LDL-C 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组TG、TC、LDL-C 水平均较治疗前降低(P<0.05),HDL-C 水平较治疗前升高(P<0.05);且观察组上述指标改善较对照组更显著(P<0.05)。研究组不良反应发生率为6.12%,对照组为2.04%,2 组比较,差异无统计学意义(P>0.05)。结论:阿托伐他汀钙片联合冠心宁片治疗可显著减轻患者颈动脉斑块,改善血脂水平,且安全性良好。

    Abstract:

    Abstract:Objective:To observe the clinical effect and safety of atorvastatin calcium combined with Guanxinning tablets for carotid atherosclerotic plaque. Methods:A total of 98 cases of patients with carotid atherosclerotic plaque were selected for prospective study,and were randomly divided into the study group and the control group,49 cases in each group. The control group was treated with atorvastatin calcium tablets,and the study group was additionally treated with Guanxinning tablets based on the treatment of the control group. Both groups were treated for three months. The changes in intima-media thickness(IMT) and maximum plaque areas in carotid artery as well as in the levels of triglyceride(TG),total cholesterol(TC), high density lipoprotein- cholesterol(HDL- C),low density lipoprotein- cholesterol(LDL- C) before and after treatment in the two groups were observed and compared; the clinical effect and the adverse reactions in the two groups were counted. Results: The total effective rate was 97.96% in the study group and 89.80% in the control group, the difference being significant(P<0.05). Before treatment, there was no significant difference being found in the comparison of IMT and the maximum plaque areas between the two groups(P>0.05). After treatment,IMT and the maximum plaque areas in the two groups were decreased when compared with those before treatment(P<0.05),and IMT and the maximum plaque area in the study group were thinner or smaller than those in the control group(P<0.05). Before treatment, when compared levels of TG ,TC,HDL-C,and LDL-C between the two groups,there was no significance being found in the difference(P>0.05). After treatment, levels of TG, TC, and LDL- C in the two groups were decreased when compared with those before treatment(P<0.05), and HDL- C level in the two groups were increased(P<0.05); the improvement of the four indexes above in the observation group was more significant than that in the control group(P<0.05). The incidence of adverse reactions was 6.12% in the study group and 2.04% in the control group,there being no significant difference between the two groups(P>0.05). Conclusion: Atorvastatin calcium combined with Guanxinning tablets can significantly reduce carotid plaques and improve blood lipid levels with good safety.

    参考文献
    相似文献
    引证文献
引用本文

陈铃,胡孝刚,陈徐彬.阿托伐他汀钙片联合冠心宁片治疗颈动脉粥样硬化斑块临床研究[J].新中医,2021,53(18):45-48

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-09-24
  • 出版日期: